Page last updated: 2024-10-25

deferoxamine and Restless Legs Syndrome

deferoxamine has been researched along with Restless Legs Syndrome in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Restless Legs Syndrome: A disorder characterized by aching or burning sensations in the lower and rarely the upper extremities that occur prior to sleep or may awaken the patient from sleep.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, X1
Wiesinger, J1
Beard, J1
Felt, B1
Menzies, S1
Earley, C1
Allen, R1
Connor, J1

Other Studies

1 other study available for deferoxamine and Restless Legs Syndrome

ArticleYear
Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome.
    Journal of the neurological sciences, 2004, May-15, Volume: 220, Issue:1-2

    Topics: Aged; Aged, 80 and over; Animals; Blotting, Western; Cell Count; Deferoxamine; Diet; Dose-Response R

2004